After finishing 11-6 and making the playoffs, the Chargers are in full offseason mode. Los Angeles is still a couple of ...

The Chargers have an opportunity to capitalize on their 2024 playoff run with an epic 2025 offseason. Here are two major ...

After building around the margins last offseason, the Chargers are positioned to make a splash in Jim Harbaugh's second ...

The Los Angeles Chargers have some heavyweight names heading to free agency this offseason, with running back J.K. Dobbins near the top of the list. Dobbins enjoyed a strong season on his one ...

J.K. Dobbins injury update: Latest update on Chargers RB's status for playoffs vs Texans J.K. Dobbins injury update: Latest update on Chargers RB's status for playoffs vs Texans J.K. Dobbins ...

Among some of the top news at the conference were M&A deal announcements by J&J, Eli Lilly and GSK. While J&J announced a big deal to acquire neuroscience company Intra-Cellular Therapies ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

What will Eli Lilly do with all its cash from Mounjaro ... Readout LOUD,” STAT’s biotech podcast, recorded live at the J.P Morgan Healthcare Conference in San Francisco. We bring on Ricks ...

Good afternoon, everybody. I'm Chris Schott at JPMorgan and it's my pleasure to be hosting this fireside chat today with Dave Ricks, Chairman and CEO of Eli Lilly. It's been a tremendous few years ...

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration, including on issues around ...

Apple AAPL3.49%increase; green up pointing triangle is defending itself in the first hearing of a $1.8 billion U.K. class action lawsuit accusing the iPhone maker of abusing its dominance in the ...